Results of Phase I/II VMAT-TMI Dose Escalation Study Of Patients Undergoing Second Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Partouche, J. [1 ]
Hasan, Y. [2 ]
Sullivan, M. [3 ]
Yenice, K. M. [4 ]
Stock, W. [3 ]
Larson, R. [3 ]
Artz, A. [5 ]
Bishop, M. [3 ]
Kosuri, S. [3 ]
Kline, J. [3 ]
Riedell, P. [3 ]
Liu, H. [3 ]
Aydogan, B. [1 ]
机构：
[1] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3759
引用
收藏
页码：E757 / E757
页数：1
相关论文
共 50 条
  • [21] Phase I Trial of a Novel Conditioning Regimen Utilizing Total Marrow Irradiation (TMI) with Fludarabine-Melphalan for Patients with Relapsed Hematologic Malignancies Undergoing Second Allogeneic Stem Cell Transplantation (Allo-SCT)
    Liu, Hongtao
    Aydogan, Bulent
    Hasan, Yasmin
    Wang, Amy
    Yenice, Kamil
    Partouche, Julien
    Stock, Wendy
    Larson, Richard A.
    Kosuri, Satyajit
    LaBelle, James
    Kline, Justin
    Riedell, Peter A.
    Artz, Andrew S.
    Bishop, Michael R.
    BLOOD, 2020, 136
  • [22] Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation: Results of a Phase I/II Study
    Yeshurun, Moshe
    Shpilberg, Ofer
    Herscovici, Korina
    Shargian, Liat
    Dreyer, Juliet
    Peck, Anat
    Israeli, Moshe
    Levy-Assaraf, Maly
    Gruenewald, Tsipora
    Mechoulam, Rafael
    Raanani, Pia
    Ram, Ron
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S353 - S354
  • [23] NOCARDIA INFECTION IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Stamouli, M.
    Bouhla, A.
    Girkas, K.
    Atta, M.
    Papanikolaou, N.
    Economopoulou, C.
    Roubakis, C.
    Vassilatou, A.
    Godopoulos, K.
    Ioannidou, E. D.
    Petevi, K.
    Pessach, E.
    Papageorgiou, S.
    Pappa, V.
    Bazani, E.
    Tsirigotis, P.
    HAEMATOLOGICA, 2015, 100 : 474 - 474
  • [24] A phase-I, dose escalation study for salvage chemotherapy for patients with refractory lymphoma, prior to myeloablative therapy with stem cell transplantation.
    Lee, CK
    de Magalhaes-Silverman, M
    Hohl, RJ
    Hayashi, M
    Schlueter, A
    Gingrich, RD
    Hohl, RJ
    BLOOD, 2000, 96 (11) : 371B - 371B
  • [25] Phase I/II study of decitabine with allogeneic peripheral blood stem cell transplantation (SCT) for treatment of relapse after allogeneic progenitor cell transplantation.
    Ravandi, F
    Kantarjian, H
    Cohen, A
    Davis, M
    O'Brien, S
    Anderlini, P
    Andersson, B
    Claxton, D
    Donato, M
    Gajewski, J
    Khouri, I
    Korbling, M
    Ueno, N
    deVos, D
    Champlin, R
    Giralt, S
    BLOOD, 1999, 94 (10) : 163A - 163A
  • [26] AmBisome® as antifungal primary prophylaxis in patients undergoing allogeneic stem cell transplantation from alternative donor: preliminary results of phase II "Prophessor" trial
    Ciceri, F.
    Bacigalupo, A.
    Bregni, M.
    Busca, A.
    Giardini, C.
    Scime, R.
    Visani, G.
    Balzano, R. L.
    Picaro, L. A.
    Aversa, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S211 - S211
  • [27] A Phase 1 Single Dose Escalation Study of Palifermin Administered Pre-Transplant Conditioning in Subjects Undergoing Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation
    Ostojic, Alen
    Holtzman, Noa G.
    Curtis, Lauren M.
    Shaffer, Brian C.
    Rubin, Jeffrey S.
    Hakim, Frances T.
    Mays, Jacqueline W.
    Heller, Theo
    Cowen, Edward W.
    Werner, Sabine
    Emanuel, Michael
    Steinberg, Seth M.
    Gress, Ronald E.
    Pavletic, Steven Z.
    BLOOD, 2020, 136
  • [28] SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) IN PEDIATRIC PATIENTS
    Ayas, M.
    Al-Jefri, A.
    Eldali, A.
    Al-seraihi, A.
    Al-Mahr, M.
    Al-Ghonaium, A.
    Al-Ahmari, A.
    Al-Mousa, H.
    Al-Mohsen, S.
    Al-Dhekri, H.
    El-Solh, H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 78 - 79
  • [29] Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
    Aksu, T.
    Kuskonmaz, B.
    Aytac, S.
    Tavil, B.
    Cetinkaya, D. Ukan
    BONE MARROW TRANSPLANTATION, 2016, 51 : S468 - S469
  • [30] Marrow cell dose is a significant predictor of outcome in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bacigalupo, A
    Dominietto, A
    Lamparelli, T
    Raiola, AM
    van Lint, MT
    Gualandi, F
    Berisso, G
    Bregante, S
    Di Grazia, C
    Frassoni, F
    BLOOD, 2000, 96 (11) : 200A - 200A
12345